Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treated advanced melanoma patients

Autor: Karadurmus, Nuri, Nahit Sendur, Mehmet Ali, Karaca, Burcak, Olmez, Omer Fatih, Hacibekiroglu, Ilhan, Coskun, Hasan Senol, Degirmencioglu, Serkan, Kemal, Yasemin, Kilickap, Saadettin, Sumbul, Ahmet Taner, Aydin, Burc, Turna, Hande, Kaplan, Muhammet Ali, Babacan, Nalan, Demirci, Umut, Ata, Alper, Erdem, Dilek, Ozet, Ahmet, Abali, Huseyin
Zdroj: In Journal of Oncological Sciences December 2018 4(3):125-129
Databáze: ScienceDirect